AbbVie Announces U.S. FDA Approval of DUOPA™ (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease
Merck Provides Update on Strategic Actions to Transform the Company and Build a Platform for Sustained Future Growth at the 33rd Annual J.P. Morgan Healthcare Conference
Vertex Outlines 2015 Business Priorities to Support the Development, Approval and Launch of New Medicines for the Treatment of People with Cystic Fibrosis
CheckMate -017, A Phase 3 Study of Opdivo (Nivolumab) Compared to Docetaxel in Patients with Second-Line Squamous Cell Non-small Cell Lung Cancer, Stopped Early
QIAGEN Announces First-ever Regulatory Registration of a Lung Cancer Companion Diagnostic Based on Liquid Biopsies
HILDEN, Germany, January 12, 2015 /PRNewswire/ --
ABBOTT PARK, Ill., Jan.
THOUSAND OAKS, Calif., Jan.
ATHENA data publication reinforces new interim guidance from medical societies on use of HPV as first-line test in cervical cancer screening
SGO, ASCCP leverage newly published end-of-study data to support option of HPV primary screening for women 25 and older
Actavis Confirms Appeals Court Grants Expedited Appeal of Ruling Requiring Continued Distribution of NAMENDA® IR
GW Pharmaceuticals and Otsuka Announce Results in First of Three Sativex(R) Phase 3 Cancer Pain Trials
- The company describes refinements to its innovation-based strategy, including greater focus on core therapeutic areas and key geographies.
New program will support the identification of novel drug targets to treat Parkinson's disease
MOUNTAIN VIEW, Calif.,